Allarity Therapeutics awarded patents for stenoparib DRP test

Allarity Therapeutics said newly awarded patents bolster its Drug Response Predictor strategy for stenoparib, aiming to strengthen commercial exclusivity by supporting the use of its stenoparib-DRP test as a companion diagnostic.